讨论
chuminhua2024-10-24 11:49
10/23，眼药制造商Ocuphire Pharma$Ocuphire Pharma(OCUP)$ 以全股票交易收购了Opus Genetics，旨在打造一家专注于开发罕见遗传性视网膜疾病基因疗法的专业公司。
合并后的实体将以Opus Genetics的名称运营，Ocuphire首席执行官George Magrath将担任首席领导。“这是一个快速推进这些治疗的机...查看全文
简介：Ocuphire Pharma
| 今开： | 昨收：1.17 |
| 最高： | 最低： |
| 涨停价： | 跌停价： |
| 总市值：30652179 |
chuminhua2024-10-24 11:49
10/23，眼药制造商Ocuphire Pharma$Ocuphire Pharma(OCUP)$ 以全股票交易收购了Opus Genetics，旨在打造一家专注于开发罕见遗传性视网膜疾病基因疗法的专业公司。
合并后的实体将以Opus Genetics的名称运营，Ocuphire首席执行官George Magrath将担任首席领导。“这是一个快速推进这些治疗的机...查看全文
Ocuphire Pharma(OCUP)2024-10-23 05:15
$Ocuphire Pharma(OCUP)$ 8-K Current report, items 1.01, 2.01, 2.02, 3.02, 3.03, 5.02, 5.03, 7.01, and 9.01 Accession Number: 0001140361-24-043915 Act: 34 Size: 6 MB 网页链接查看全文
Ocuphire Pharma(OCUP)2024-08-14 04:15
$Ocuphire Pharma(OCUP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001140361-24-037068 Act: 34 Size: 7 MB 网页链接查看全文
Ocuphire Pharma(OCUP)2024-08-13 20:25
$Ocuphire Pharma(OCUP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001140361-24-036944 Act: 34 Size: 357 KB 网页链接查看全文
Ocuphire Pharma(OCUP)2024-06-14 05:35
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001710 Size: 16 KB 网页链接查看全文
Ocuphire Pharma(OCUP)2024-06-14 05:35
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001711 Size: 16 KB 网页链接查看全文
Ocuphire Pharma(OCUP)2024-06-14 05:35
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001712 Size: 16 KB 网页链接查看全文
Ocuphire Pharma(OCUP)2024-06-14 05:35
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001714 Size: 16 KB 网页链接查看全文
Ocuphire Pharma(OCUP)2024-06-14 05:35
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001713 Size: 7 KB 网页链接查看全文
Ocuphire Pharma(OCUP)2024-06-14 05:25
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001709 Size: 16 KB 网页链接查看全文
$Ocuphire Pharma(OCUP)$ 8-K Current report, items 1.01, 2.01, 2.02, 3.02, 3.03, 5.02, 5.03, 7.01, and 9.01 Accession Number: 0001140361-24-043915 Act: 34 Size: 6 MB 网页链接
$Ocuphire Pharma(OCUP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001140361-24-037068 Act: 34 Size: 7 MB 网页链接
$Ocuphire Pharma(OCUP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001140361-24-036944 Act: 34 Size: 357 KB 网页链接
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001710 Size: 16 KB 网页链接
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001711 Size: 16 KB 网页链接
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001712 Size: 16 KB 网页链接
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001714 Size: 16 KB 网页链接
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001713 Size: 7 KB 网页链接
$Ocuphire Pharma(OCUP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-001709 Size: 16 KB 网页链接
$Ocuphire Pharma(OCUP)$ 8-K Current report, items 5.03, 5.07, and 9.01 Accession Number: 0001140361-24-030012 Act: 34 Size: 519 KB 网页链接